>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
CK19、CK20 mRNA在上皮性恶性肿瘤患者外周血中的表达及其意义
作者:郭英1 黄培林2 王景美1 谢维3 
单位:1.东南大学基础医学院病理学与病理生理学系,江苏南京,210009; 2.东南大学基础医学院病理学与病理生理学系,江苏南京,210009;东南大学遗传学研究中心,江苏南京,210009; 3.东南大学遗传学研究中心,江苏南京,210009
关键词:肿瘤 腺和上皮 RNA 信使/血液 角蛋白/血液 逆转录-聚合酶链反应 
分类号:Q503, Q522.2, R730.261, R730.43
出版年·卷·期(页码):2003·22·第一期(9-12)
摘要:

目的:分析上皮性恶性肿瘤患者外周血中CK19、CK20 mRNA的表达水平,探讨其临床病理意义.方法:随机选择和收集53例上皮性恶性肿瘤患者的外周血,应用巢式RT-PCR法联合检测其CK19、CK20 mRNA表达情况.另取15例上皮性肿瘤组织为阳性对照,15例非肿瘤患者外周血为阴性对照.结果:53例肿瘤患者外周血中CK19阳性率为35.8%(19/53),CK20阳性率41.5%(22/53),两者至少1项阳性者69.8%(31/53).15例肿瘤组织中CK20阳性率为100%(15/15),CK19阳性率86%(13/15);15例阴性对照CK19阳性2例,CK20阳性1例.结合肿瘤的临床病理资料分析,肿瘤患者外周血CK19、CK20 mRNA 阳性表达与肿瘤浸润深度、临床分期及淋巴结转移间存在明显的相关性,而与肿瘤患者的年龄、性别、肿瘤分化程度无明显相关.结论:CK19、CK20 mRNA可作为检测上皮性肿瘤外周血微转移的靶基因.联合检测肿瘤患者外周血CK19、CK20 mRNA可增加外周血循环癌细胞的检测率.

Objective  To study the abnormal expression of CK19,CK20 mRNA in the peripheral blood for epithelial malignancies patients,and to explore its clinical significance.Methods  A total of 53 preoperative peripheral blood specimens were obtained from patients with epithelial malignancies.RT?PCR assay was applied to detect the expression of CK19,CK20 mRNA in the peripheral blood.As control,15 fresh tumor tissues and blood samples from 15 patients with inflammatory disease,were also obtained.Results  The positivity for CK19 and CK20 mRNA expression were 35.8%(19/53) and 41.5%(22/53),respectively,69.8%(31/53) were positive of either one in peripheral bood from patients with epithelial cancers.In primary tumors,15 tumor tissues were all positive for CK20 mRNA,and 86%(13/15) were positive for CK19 mRNA.In blood samples from nonmalignant control subjects,2 were positive for CK19,and only one was positive for CK20.The expression of the two genes (CK19 and CK20) were significantly correlated with clinical pathologic stage,lymph node metastasis and depth of invasion,but had no coincidence with differentiation,sex and age of the patients.Conclusion  These data indicate the CK19,CK20 mRNA expression may be potential biomarkers for detecting micrometastasis and recurrence in peripheral blood with epithelial cancers.

参考文献:

[1] Peck K, SHER Y P, SHIN J Y. Detection and quantitation of circulating tumor cells in the peripheral blood of lung cancer patients, 1998(13)
[2] Gerhard M, JUHL H, Kalthoff H. Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction, 1994(4)
[3] FUNAKI N O, TANAKA J, OHSHIO G. Cytokeratin 20 mRNA in peripheral venous blood of colorectal carcinoma patients, 1998(8)
[4] Schoenfeld A, LUQMANI Y, Smith D. Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction, 1994(11)
[5] Stasiak P C, LANE E B. Sequence of cDNA coding for human cytokeratin 19. 1987(23). doi:10.1093/nar/15.23.10058
[6] Stasiak P C, PURKIS P E, LEIGH I M. Keratin 19:predicted amino acid sequence and broad tissue distribution suggest it evolved from keratinocyte keratins. 1989(5). doi:10.1111/1523-1747.ep12721500
[7] FUNAKI N O, TANAKA J, ITAMIA. Detection of colorectal carcinoma cells in circulating peripheral blood by reverse transcription-polymerase chain reaction targeting cytokeratin-20 mRNA. 1997(9). doi:10.1016/S0024-3205(96)00700-X
[8] 刘永昌, 梁小波, 孙俊宁. 结直肠癌向肝转移的观察. 中国肿瘤临床2000(1). doi:10.3969/j.issn.1000-8179.2000.01.010 

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 465082 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

本系统由北京博渊星辰网络科技有限公司设计开发 技术支持电话:010-63361626

苏ICP备09058364